Will general antiviral protocols always be science fiction?

Society relies entirely on medicinal chemists to pre-select new drug candidates for clinical trialing. Could they be overlooking a selectivity mechanism for antivirals hiding in plain sight?

[Update - the source article for this piece is now published in Frontiers in Pharmacology ]

This article is now hosted at The Seeds of Science substack - check it out!

---